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amplitude 
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NPV Negative predictive value 
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PPV Positive predictive value 
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tpLDF Time to peak hyperaemic 
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Abstract 
Background: Diabetic foot disease carries a high morbidity and is a leading 
cause of lower limb amputation.  This may in part be due to the effect 
diabetes mellitus (DM) has on the microcirculation including in the skin.   
Method: We conducted a review of studies that have examined the 
relationship between microcirculatory function and wound healing in 
patients with DM.  A search of the Medline, EMBASE and Web of science 
databases was performed coupled with a review of references for the period 
1946 to March 2015. 
Results: Nineteen studies of diverse methodology and cohort selection were 
identified.  Poor function of the microcirculation was related to poor 
outcome.  Transcutaneous oxygen pressure (TcPO2) was the most commonly 
used method to measure the microcirculation and thresholds for poor 
outcome proposed ranged from 10mmHg to <34mmHg.   Two studies re-
examined microcirculatory function following revascularisation. Both found 
an increase in TcPO2 however only one reached statistical significance.  No 
significant difference in the results of microcirculation tests was found 
between diabetic and non-diabetic patients.   
Conclusions:  While it is not possible to draw firm conclusions from the 
evidence currently available there are clear areas that warrant research. 
Good microcirculation unsurprisingly appears to associate with better wound 
healing.  The influence of DM is not clear, and neither is the degree of 
improvement required to achieve healing.  Studies that examine a clearly 
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defined cohort both with and without DM are urgently required. Accurate 
quantitative assessment of microcirculation will aid prediction of wound 
healing identifying those at greatest risk of amputation. 
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Introduction 
Currently, 3.2 million people in the United Kingdom (UK) and 29.1 million 
people in the United States of America (USA) are diagnosed with diabetes 
mellitus (DM), accounting for 6% and 9.3% of the population respectively1,2. 
It is estimated that the lifetime incidence of a foot ulcer may be as high as 
25% among these patients with an associated increased risk of amputation3.  
Diabetic ulceration and associated amputation also carry a significant cost 
burden to society, this will continue to increase along with the rising 
incidence of DM4.   
DM is known to have a significant effect on the microvasculature, causing 
dysfunction of the arterioles and capillaries supplying the retina, kidneys and 
peripheral nerves5, histological examination of capillaries has shown 
thickening of the basement membrane compared to non-diabetic patients6-8. 
Different methods to quantifiably examine the microcirculation and its 
function have been developed; these include capillary microscopy (CM), 
transcutaneous oxygen pressure (TcPO2) and laser Doppler fluxmetry (LDF). 
How these measures of the microcirculation change with wound healing is 
not well described. The review that the International Working Group on the 
Diabetic Foot Guidance on prognosis is based on is a through and well 
performed systematic review9. However the focus of the review is not on 
methods of assessing the microcirculation and while the discussion and 
conclusion consider TcPO2 the results that this conclusion is based on are not 
covered in the results. There is also no consideration of comparison to 
patients without DM or the role of repeated measures. The aim of this review 
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was to examine the current evidence available on the relationship between 
the microcirculation in the ulcerated diabetic foot and wound healing. 
Specifically the ability to predict healing, how the results for those with DM 
compare to those without and how the results vary when repeated 
measurements are taken. 
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Methods 
A search of the Medline, EMBASE and Web of Science databases was 
performed.  The search strategy consisted of the Medical Subject Headings 
(MESH) “microcirculation”, “wound healing”, “diabetic foot”, “skin ulcer”, 
“laser Doppler flowmetry”, “blood gas monitoring, transcutaneous”, 
“microscopic angioscopy”, “xenon radioisotopes”.  In addition a key word 
search was performed.  The terms used can be found in Appendix I.  Non-English language and non-human studies were excluded, the date range for the search was 1946 to February 2015.  Final inclusion in the review 
was dependant on meeting the criteria set out in Table 1, no limits were 
applied to length of follow up or number of patients included.  
One reviewer (DL) performed the search, reviewed abstracts and selected 
studies for inclusion. Any areas of uncertainty were reviewed by the senior 
author (AT) to provide a second opinion. The original intention was to 
perform a meta-analysis however there were insufficient numbers of high 
quality studies to be able to continue this plan and so a more descriptive 
approach was taken to reporting the data.  
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Results 
Two-hundred and eighty-seven articles were identified after searching the 
databases.  Full text was obtained for all abstracts that met the inclusion 
criteria and all relevant data was extracted.  After this assessment and review 
of references nineteen studies were included in the final review (Figure 1) 10-
28.  The date of publication ranged from 1985 to 2014, two studies were 
randomised control trials (RCTs), there were three pseudo-RCTs and the rest 
were observational studies (Table 2). Not all studies included all the 
comparisons considered below and some studies used more than one 
method to assess the microcirculation. 
Using the microcirculation to predict healing 
Twelve studies out of nineteen compared the microcirculation in patients 
with diabetes who healed to those who did not heal10-12,15,18-21,24,26-28.  Ten of 
these studies employed TcPO211,12,15,18,20,21,24,26-28, five used LDF11,15,20,21,28, 
one used laser Doppler imaging (LDI)19 and one used isotope washout to 
measure skin perfusion pressure (SPP)10.  These were all observational 
studies apart from one which randomised the first 14 of its participants but 
not the final 2420.  For seven of the studies the participants received only 
standard therapy 10-12,15,26,27.  Two studies examined the effects of HBO 
therapy, Kalani et al (2002) had 2 cohorts, one of which received standard 
therapy and the other which received HBO.  The healed and unhealed groups 
in this study are made up of participants from either cohort20.  Fife et al 
performed a retrospective study of 1144 patients who received HBO 
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therapy18.  Klingel et al reported the results of a very small pilot study (8 
patients) all of whom received rheopheresis21.  Two studies treated their 
participants with dermal replacement therapy (Ichioka et al bone marrow 
impregnated collagen).  Newton et al, collagen containing 
glycosaminoglycans)19,24.  Five studies only investigated patients with both 
diabetes and ischaemia11,15,18,20,21, three studies excluded those with 
ischaemia12,19,24, in one study it was unclear26 and three included a mix of 
patients10,27,28.  Only Yotsu et al divided the patients into groups depending in 
their aetiology (neuropathic, ischemic and neuro-ischemic)28.   
Transcutaneous oxygen pressure 
Nine studies used TcPO2 to predict wound healing11,12,15,20,21,24,26-28, the results 
are summarised in Table 3.  Five studies found that those with a higher TcPO2 
had a statistically significant higher chance of healing, with results ranging 
from 30±4mmHg to 61.11±21.16mmHg 11,15,21,26,27.  Kalani et al 2002 and 
Yotsu failed to find a significant difference between the two groups20,28.  
Pecoraro et al found a significant difference between those who had early 
healing and those who did not (56.3±2.72mmHg vs 26.9±8.26mmHg, 
p=0.003) however was unable to demonstrate that the difference had 
persisted in those that healed overall (53.67±2.99mmHg vs 
37.57±11.02mmHg, p=0.126)12. 
Skin perfusion pressure 
Two papers used SPP to compare the healed and unhealed groups10,28.  Faris 
et al in 1985 used an isotope washout method on 64 patients with diabetes 
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and foot ulceration or gangrene.  Those who healed had a mean SPP of 59 ± 
16mmHg compared to those who did not heal whose mean SPP was 35 ± 11 
(p<0.001)10.  Yotsu et al in 2014 employed LDF instead of isotope washout to 
measure SPP on diabetic ulcers divided into the groups described above.  
They found that neuropathic ulcers had a higher SPP than both ischemic and 
neuro-ischemic ulcers, 65 ± 13.6mmHg, 27 ± 14.1mmHg and 34 ± 23.2mmHg 
respectively (p<0.001).  However there was no significant difference between 
the healed and unhealed ulcers in each group (Table 4)28. 
Laser Doppler 
Karanfilian et al was the only paper to use laser Doppler fluxmetry to 
compare between healed and unhealed patients.  They demonstrated 
significantly higher skin blood flow velocity (LD-SBFV) and pulse wave 
amplitude (LD-PWA) results between those who healed and those who did 
not in both their study groups (Table 5)11.    
Prediction of healing 
Three studies reported the accuracy of cut-off values for healing10,15,18.  Faris 
and Duncan found a SPP of less than 40mmHg was an indicator of poor 
healing  (sensitivity of 97%, specificity 80%, positive predictive value (PPV) 
87% and negative predictive value (NPV) 95%)10. Kalani et al (1999) used a 
cut-off of 25mmHg for TcPO2 and 30mmHg for toe blood pressure (TBP) using 
LDF. For TcPO2 the sensitivity was 85%, specificity 92%, PPV 79% and NPV 
94%.  For TBP the sensitivity was 15%, specificity 97%, PPV 67% and NPV 
77%15.  Fife et al tested multiple potential cut-offs for sea level TcPO2 as a 
predictor of failure of hyperbaric therapy.  They found that 25mmHg was the 
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best cut-off with a 2.5 times greater chance of success.  However the 
accuracy was still relatively poor with sensitivity of 67%, specificity 50%, PPV 
35% and NPV 79%18. 
Diabetes compared to no diabetes 
Two out of nineteen studies compared subjects both with DM and without 
DM11,14.  Both of these papers used TcPO2 to make their comparisons, in 
addition Karanfilian et al employed LDF11  
Padberg et al reported the predictive accuracy for healing of TcPO2 in 
critically ischaemic wounds.  204 wounds were stratified depending on the 
presence of DM, dialysis dependant chronic renal failure or neither disease.  
Probability of healing curves for each group were plotted and compared 
using multiple logistic regression.  TcPO2 in DM patients had a predictive 
accuracy, sensitivity and specificity of 81%, for chronic renal failure these 
figures were 77%, 73% and 82% respectively, and for neither disease 84%, 
86% and 82%14.  
Only one study identified compared the mean results of microcirculatory 
tests for patients with diabetes and those without11.  The patients were all 
men with ulceration to the foot (34 with diabetes, 22 without).  One off 
measurements of TcPO2 and LDF (LD-SBFV and LD-PWA) and follow up of at 
least 30 days was performed. The results are presented in Table 5. Patients 
without diabetes who did not heal had a lower TcPO2, LD-SBFV and LD-PWA 
than patients with diabetes who did not heal.  In the healed groups for the 
patients without diabetes the TcPO2 was higher than the patients with 
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diabetes.  However the LD-SBFV and LD-PWA were lower in the group 
without diabetes.  The authors have not reported whether these differences 
are statistically significant11. 
Multiple measurements during observation period 
Eight out of nineteen studies reported the results of more than one 
measurement on the same group of patients13,16,19,21-25.  One study detected 
no change, two noted a decrease in reading, a further two noted an increase 
and three noted a pattern of increasing then decreasing.  Jorneskog et al 
used LDF and capillary microscopy to examine 10 patients with diabetes who 
received low molecular weight heparin for a period of eight weeks.  
Measurements of the microcirculation (post occlusive reactive hyperaemia 
(PORH), structural appearance of capillaries in the forefoot and toes) were 
undertaken 1-2 weeks prior to receiving heparin, after 4-7 weeks of 
treatment and two weeks after treatment was stopped.  They found that 
there was no significant change in any of the laser Doppler parameters during 
or after treatment.  It was however noted that six patients who had improved 
healing also had an improvement in their capillary stage, three others also 
improved clinically but one had no change in their capillaries, one initially 
improved but then deteriorated again and in one it was not possible to 
determine their capillary stage.  One patient deteriorated both clinically and 
on microscopic examination13.   
Petrofsky et al published on electronic stimulation (ES) for diabetic foot 
ulcers in both 2007 and 201022,25.  In 2007 the study groups were, ten 
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patients who received global heating and ES, nine who received local heating 
and ES and ten patients who received conventional therapy only.  The 
measure of the microcirculation was blood flow using LDI (measured in 
arbitrary unit flux). The control group did not undergo LDI measurement, only 
wound area was measured.  In 2010 the aim of the study was to examine the 
role that heating had compared to ES and heating. Ten patients received local 
heating only and a further ten local heating and ES.  The treatment period for 
both studies was four weeks.  In both studies the blood flow around and in 
the ulcer had decreased by the end of the study. In the 2007 study the mean 
blood flow at baseline was reported for 1cm from the ulcer (182.3±26.1 
increasing to 245.0±28.5 with ES) and the edge of the ulcer (223.4±34.1 
increasing to 301.0±29.3 with ES). The result for the centre of the ulcer is 
reported as being similar and is illustrated in a graph but the actual values are 
not stated.  At four weeks only the values for the centre of the ulcer are 
stated (228±36.2 increasing to 256.7±46.3 with ES). The change in blood flow 
before and during ES at baseline and at four weeks is displayed in Table 6; 
there was a significant reduction in the increase at four weeks (<0.01). The 
results for the local heating group are illustrated in a graph and stated as 
being similar but of a smaller magnitude to the global group but the actual 
mean values are not quoted22. In 2010 Petrofsky found that the mean resting 
blood flow from all three areas and both groups had reduced by 54.5±22.3% 
after four weeks25. 
Lawson et al as described above also investigated the effect of electrical 
stimulation on wound healing.  They measured blood flow at the centre and 
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outside of the ulcer using LDI at baseline, two weeks and four weeks.  When 
looking at the outside of the ulcer the pre-stimulation results for the DM 
group showed larger increase in the blood flow than for the non-DM group 
(DM, 0-2 weeks 35%, 0-4 weeks 21%; Non-DM, 0-2 weeks 0%, 0-4 weeks 
18%).  However at the centre of the wound the non-DM had a greater 
increase (DM, 0-2 weeks 8%, 0-4 weeks 5%; Non-DM, 0-2 weeks 22%, 0-4 
weeks 38%).  The statistical significance of these results is not reported23.   
Koblik et al performed an RCT comparing optimisation of insulin therapy and 
injection of an antithrombotic drug (sulodexide) with optimisation of insulin 
therapy and placebo injections for 10 weeks.  Measurements were taken at 
baseline and eight weeks using LDF.  The parameters measured were resting 
flux (RF), peak hyperaemic flow (pLDF), time to peak hyperaemic flow (tpLDF) 
and hyperaemia duration (HD) after an occlusion of thirty seconds.  These 
measures were repeated following a sixty-second occlusion once the 
readings had stabilised.  In the placebo group (6 patients) there was no 
significant change in the RF at eight weeks (Baseline: mean flux 11.6± 
standard error of mean 1.3. Eight weeks 12.3±1.1. p = ns).  The pLDF for both 
the thirty (51.7±15.2 to 147.0±16.2, p<0.01) and sixty second occlusion 
(110.5±13.0 to 164.8 ±15.4, p<0.01) significantly increased at eight weeks16.   
The results from two studies with small numbers are presented in graphical 
form in Figure 2.  Newton et al’s 7 ulcers all healed or showed improvement 
at eight weeks.  Four measurements using LDI were performed at baseline, 
two, five and eight weeks.  Four patients had an increase in blood flow over 
the first few weeks followed by a decrease to below baseline at eight weeks. 
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One increased throughout the measurement period.  One decreased at two 
weeks, increased at weeks five and eight but did not return to baseline level. 
One decreased throughout (Figure 2a).  Those that had healed at eight 
weeks, two increased then decreased, one increased throughout and the 
other decreased throughout19.  Of Klingel’s eight patients who received 
rheopheresis five underwent TcPO2 at baseline, twelve and twenty-four 
weeks and three underwent TcPO2 at baseline and twelve weeks (due to 
minor amputation in one patient and major amputation in two).  Of the four 
patients who showed an improvement in their ulcer two had an increase in 
blood flow followed by a decrease, the other two increased throughout.  In 
the patients whose ulcers were unchanged one increased TcPO2 at twelve 
weeks, the other increased at both twelve and twenty-four weeks. Of the 
two patients who deteriorated one had a small increase at twelve weeks and 
the other had a small decrease (Figure 2b)21. 
Ichioka et al in their DM subgroup showed, in graphical form, a trend of 
increasing TcPO2 in the healed group and a decrease at 4 days in the 
unhealed group.  The mean TcPO2 at 4 and14 days are not reported, however 
logistic regression analysis showed the results at these time point 
contributed significantly to the prediction of outcome (p<0.001 and 0.002 
respectively)24. 
Discussion 
Within this group of studies the most commonly used method to assess the 
microcirculation was TcPO2 (n=12), followed by LDF (n=7), LDI (n=4), capillary 
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microscopy (n=2) and isotope washout (n=1).  These proportions are 
probably representative of the current state of clinical usage of these 
methods with TcPO2 and LDF being the most common.  
Within this group of studies, a variety of methods for examining the 
microcirculation have been used.  Some of these methods have now fallen 
out of favour as technology has developed less invasive methods.  This 
includes Xe clearance and SPP using isotope washout.  LDF, TcPO2 and 
capillary microscopy remain in regular use.  LDF is relatively 
underrepresented in this cohort, which is surprising considering that its utility 
in evaluating patients with critical limb ischaemia is well-documented29-31.  
One reason for this may be the relative age of many of the studies included 
(only three since 2000 and going back as far as 1978).  TcPO2 was the most 
commonly used method in this review, which fits with its presence in the 
literature on critical limb ischaemia and diabetic foot disease as a whole.   
There is disagreement on how to carry out each of the methods of assessing 
the microcirculation, including positioning of the probes and in the case of 
TcPO2 the skin temperature that recordings were made at.  Probes were 
most commonly positioned on the dorsum of the foot11,12,15,17,20,26,27, but they 
are also positioned peri-wound12,18,21,24 and in one case it was not stated14.  A 
possible explanation for Yotsu et al not detecting a significant difference is 
their method of measurement28.  Multiple measurements were taken in two 
areas of the foot and the lowest result recorded.  Of particular note, the 
contra-lateral foot was used if there was extensive ulceration, this may well 
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have skewed their results.  TcPO2 was most commonly measured at 
44oC12,15,18,20,21,24 but also at 45oC 11,14 or not stated17,26-28  
Due to the variety of countries and inclusion/exclusion criteria, the cohorts 
differed across the studies.  For example, Yang26 and Lawson23 excluded 
patients with evidence of osteomyelitis whereas most of the other studies 
did not.   
Unsurprisingly, the overall trend from the results is that if the 
microcirculation is functioning poorly then wound healing is poorer and 
outcomes are worse.  Due to the larger number of studies, TcPO2 best 
demonstrates this.  Most studies demonstrated a significantly higher TcPO2 in 
those patients who healed.  What is less clear is the threshold at which 
healing occurs.  The TcPO2 thresholds quoted for successful outcome in this 
review range from 10mmHg to 34mmHg.  Karanfilian quotes sensitivity of 
100% and specificity of 88% for healing if the TcPO2 is >10mmHg11.  Pecoraro 
found that a TcPO2 of <20mmHg was associated with a 39 fold increased risk 
of early healing failure12.  Both Kalani and Yang used the threshold of 
<25mmHg and quoted sensitivities and specificities of 85% Vs 92% and 88.6% 
Vs 82.4% respectively15,26.  This threshold, when looking at the collated 
results in the healed and unhealed groups in Table 3, appear to hold true 
when considering the healed groups, all the mean results are above 
25mmHg.  However it is worth observing that the mean TcPO2 is also higher 
than 25mmHg in six of the unhealed groups12,24,27,28.  The current consensus 
among experts is that patients with a SPP ≥40mmHg, TBP ≥45mmHg or TcPO2 
≥25mmHg are more likely to heal than their counterparts with poorer 
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perfusion and that a TBP <30mmHg or TcPO2 <25mmHg is an indication for 
urgent vascular imaging9,32. This is based on a recent review examining the 
utility of prognostic markers in diabetic foot disease in which the authors 
faced similar difficulties to us in identifying studies of sufficient quality to 
draw conclusions from9.  Eventually eleven studies involving 5890 patients 
were included however there was still significant heterogeneity and 
difference in the measures used.  Their conclusions were based 
predominantly on three papers of acceptable rather than high quality 
(Quality in Prognosis Studies Tool)10,15,33. 
Only one study in this current review truly compared the results of testing 
the microcirculation in patients with DM and those without11.  Karanfilian 
found that the DM patients who healed had a lower TcPO2 than non-DM 
patients who healed.  Conversely the LDF results were higher in the DM 
healed group.  In the unhealed groups the opposite is true.  The accuracy of 
TcPO2 for predicting healing is shown to be reasonable in those with DM, 
slightly poorer than those without DM but better than those with CRF.  It is 
hard to explain this pattern however cohort selection may offer an 
explanation as the non-DM cohort had significant PVD whereas the DM 
cohort was made up of a mix of patients with diabetic foot disease, with and 
without PVD11.  
The results from the repeated measures suggest that there is a change in the 
microcirculation during healing but the true trend and how it relates to 
healing has not yet been identified. 
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Conclusions 
Due to the heterogeneity of the cohorts and the data presented it is not 
possible to draw any firm conclusions from a review of the current literature.  
We can, however, surmise that good microcirculation associates with better 
wound healing.  The influence of DM and associated neuropathy is not clear, 
and neither is the degree of improvement required to achieve healing.  
Studies that examine a clearly defined cohort both with and without DM are 
urgently required. Accurate quantitative assessment of microcirculation will 
greatly aid predicting feet at risk, of predicting wound healing with and 
without surgery, and for identifying those at greatest risk of amputation.
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Figures 
Table 1: Review Inclusion criteria  
Inclusion criteria 
• English language article 
• At least one method of assessing the microcirculation 
• Patients with active tissue loss 
• Wound healing as an outcome measure 
• Results from patients with diabetes to be analysed separately from 
patients without diabetes in one of the following three formats. 
o Patients with diabetes compared to patients without diabetes 
o Patients with diabetes who healed compared to patients with 
diabetes who did not heal 
o Repeated measurements from the same patient during the 
period of active diabetic ulceration being investigated 
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Figure 1: Flow diagram illustrating study identification process 
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Table 2: Characteristics of included studies  
Author Year Country Type of study Microcirculation method 
Number of subjects 
DM Non-DM 
       
Faris, I.10 1985 Australia Cross-sectional SPP using isotope washout 64 - 
       
Karanfilian, R.11 1986 USA Cohort 1)LDF  2)TcPO2 
34 22 
       
Pecoraro, R.E.12 1991 USA Cross-sectional 1) TcPO2  2) TcPCO2 
46 - 
       
Jorneskog, G.13 1993 Sweden Cross-sectional 
1)LDF-PORH 
2)Capillary 
microscopy 
10 - 
       
Padberg, F.T14 1996 USA Case control TcPO2 129 97 
       
Kalani, M.15 1999 Sweden Cross-sectional 1) TcPO2 2)TBP using LDF 50 - 
       
Koblik, T.16 2001 Poland Double blind RCT 
LDF, PORH and 
resting flow 18 - 
       
Zimny, S.17 2002 Germany Cross-sectional TcPO2 31 - 
       
Fife, C.E.18 2002 USA Cross-sectional (retrospective) TcPO2 1144 - 
       
Newton, D.J.19 2002 UK Cross-sectional LDI 5  
       
Kalani, M.20 2002 Sweden Pseudo-RCT 
1) TcPO2 + 
TcPCO2 during 
O2 inhalation  
2)TBP using LDF 
38 - 
       
Klingel, R.21 2003 Germany Cross-sectional 
1) TcPO2 
2)LDF  
3)Capillary 
microscopy 
8 - 
       
Petrofsky, J.S.22 2007 USA Pseudo-RCT LDI 29 - 
       
Lawson, D.23 2007 USA Pseudo-RCT LDI 10 10 
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Ichioka, S.24 2009 Japan Case control TcPO2 31 22 
       
Petrofsky, J.S.25 2010 USA RCT LDI 20 - 
       
Yang, C.26 2013 China Cross-sectional TcPO2 61 - 
       
Wang, A.27 2014 China Cross-sectional TcPO2 194 - 
       
Yotsu, R.R.28 2014 Japan Cohort 1)SPP using LDF 2) TcPO2 
73 - 
       
Abbreviations:  RCT – randomised control study, SBF – skin blood flow, SPP – skin perfusion pressure, SVR – 
skin vascular resistance, LDF – laser Doppler fluxmetry, TcPO2 – transcutaneous oxygen pressure, TcPCO2 – 
transcutaneous carbon dioxide pressure,  PORH – post occlusive reactive hyperaemia, TBP – toe blood 
pressure, LDI – laser Doppler imaging. 
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Table 3: TcPO2 results for patients who healed compared 
to patients who did not heal. 
Author Measurement/groups 
TcPO2 (mmHg) p 
Healed (n) Unhealed (n) 
Klingel21 Mean change in TcPO2 week 0-12.  Improved and deteriorated groups 
13.23±9.57 
(4) 
-2.3 ± 6.65 
(2) <0.05* 
     
Kalani 
(2002)20 
Basal TcPO2, dorsum of foot.  
All patients 
26 ± 10 
(23) 
24 ± 10  
(9) ns 
     
Karanfilian1
1 
Dorsum of foot.  
All diabetic patients 
30 ± 4  
(16) 
7 ± 2.5  
(18) <0.05 
     
Yang26 
Dorsum of foot.  
Group 1 (ulcers healed with intact 
skin),  
Group 3 (Ulcers that did not heal 
or deteriorated including requiring 
amputation) 
32 ± 10 
(36) 
15 ± 12  
(17) <0.001 
     
Ichioka24 
Peri-wound TcPO2.  
Diabetic subgroup (combination of 
treatment and conventional 
therapy group) 
34.5 ±19.2 
(32) 
26.4 ±16.7 
(10) 
Not 
stated 
     
Yotsu†28 
Multiple measures from 2 areas 
on foot, lowest value recorded. 
Contralateral foot used if 
extensive ulceration.  
Ischaemic group 
38, 12-40 
(9) 
30, 3-45 
(11) ns 
Neuro-ischaemic group 
38, 22-51 
(9) 
17, 16-32  
(5) ns 
Neuropathic group 
48, 40-56 
(34) 
44, 43-50  
(5) ns 
     
Kalani 
(1999)15 
Dorsum of foot. Healed with intact 
skin compared to impaired ulcer 
healing 
50 ± 20 
(20) 
13 ± 14  
(13) <0.001 
     
Pecoraro12 
Peri-wound TcPO2 overall healing 
53.67±2.99 
(39) 
37.57±11.02 
(7) ns 
Peri-wound TcPO2 early healing 
56.3 ± 2.72 
(38) 
26.9 ± 8.26 
(8) 0.003 
     
Wang27 Site of measurement not stated.  Healing and non-healing groups 
61.11±21.1
6 (162) 
46.5 ± 18.06 
(20) <0.01 
*Wilcoxon test for matched pairs for significance of change between weeks 0-12 for each group 
separately.  All values mean ± SD apart from †median and IQR reported 
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Table 4: Skin perfusion pressure results for patients who 
healed compared to patients who did not heal28. 
Group SPP (mmHg) p 
Healed (n) Unhealed (n) 
Neuropathic 67, 57-75 (34) 65, 40-69 (5) 0.192 
Ischemic 37, 17-43 (9) 20, 15-37 (11) 0.341 
Neuro-ischemic 38, 22-51 (9) 17, 16-32 (5) 0.141 
All values median, IQR 
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Table 5: TcPO2 and LDF results in patients with diabetes 
compared to patients without diabetes11. 
 Diabetes 
(Mean ± SE) 
No diabetes 
(Mean ± SE) 
 Healed (16) Unhealed (18) Healed (15) Unhealed (7) 
TcPO2 
(mmHg) 
30 ± 4.0 7 ± 2.5* 42 ± 3.5 2 ± 1.6* 
LD-SBFV (mV) 98 ± 13.0 50 ± 8.0* 88 ± 15.0 37 ± 2.0* 
LD-PWA (mV) 14 ± 3.0 4 ± 0.5* 8 ± 1.4 2 ± 0.3* 
* Significant difference between healed and unhealed groups (p<0.05) 
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Table 6: Change in blood flow associated with electrical 
stimulation at baseline and at four weeks (global heating 
group only)22 . 
Position of 
measurement 
Flux±SD p-value Baseline (10) Week four (10) 
1cm from ulcer 63.5±11.9 18.3±10.8 
<0.01 Edge of ulcer 77.6±11.6 48.7±9.6 
Centre of ulcer 33.6±3.1 28.4±15.8 
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Figure 2: Trends during healing for LDI and TcPO2. A: Adapted from 
Newton et al.19 Solid line, ulcers healed Alternating dashed line ulcers 
improved. B: Adapted from Klingel et al.21 Small dashed line ulcers 
deteriorated. 
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Appendix I: Search strategy 
MESH Search 
Search Search terms 
1 microcirculation 
2 wound healing 
3 diabetic foot 
4 skin ulcer 
5 Laser Doppler flowmetry 
6 blood gas monitoring, transcutaneous 
7 Microscopic angioscopy 
8 Xenon radioisotopes 
9 3 or 4  
10 5 or 6 or 7 or 8 
11 1 and 2 and 9 and 10 
12 11 limited to English and humans 
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Keyword search 
Search Search terms 
1 
capillar* or venule* or arteriole* or small adj2 vessels or skin microcirculation or skin blood 
supply or skin blood flow or microangiopath* or microcircula* disturbance* 
  
2 
transcutaneous adj3 oxygen* or transcutaneous PO2 or transcutaneous oximetry or 
transcutaneous adj3 carbon dioxide or TcPO2 or TcPCO2 
  
3 
laser Doppler* or laser Doppler fluxmetry or laser Doppler Imaging or laser Doppler 
velocimetry or laser Doppler flux or LDF or LDI or Post occlusive reactive hyperaemia or PORH 
  
4 capillary microscopy or capillary pressure or capillaroscopy  
  
5 skin adj2 pressure or skin adj2 perfusion 
  
6 xenon clearance or isotope clearance or haemodynamic test* or venoarteriolar response 
  
7 2 or 3 or 4 or 5 or 6 
8 
wound* or ulcer* or ulcer healing or tissue loss or healing or wound complication* or non-
healing or nonhealing or granulation tissue or amputat* 
  
9 1 and 7 and 8  
  
10 9 limited to English and humans only 
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